The successful trials come after Starlink rival AST SpaceMobile also used its newly launched satellites to power a video call ...

Fintel reports that on February 24, 2025, JP Morgan upgraded their outlook for bluebird bio (NasdaqGS:BLUE) from Underweight ...

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed ...

JPMorgan upgraded Bluebird Bio (BLUE) to Neutral from Underweight without a price target after the company entered into a definitive agreement ...

Verizon and AST have yet again pushed the boundaries of what can be done with mobile devices by successfully trialing a live ...

Wells Fargo analyst Yanan Zhu lowered the firm’s price target on Bluebird Bio (BLUE) to $5 from $40 and keeps an Equal Weight rating on the ...

Verizon and AT&T have each announced milestones in making cellphone-to-satellite video calls in partnership with satellite ...

The following is a listing of all home transfers in Somerset County reported from Feb. 17 to Feb. 23. There were 23 ...

Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...

AST SpaceMobile (NASDAQ: ASTS), a producer of low earth orbit (LEO) satellites for cellular networks, saw its stock soar more ...